Pathogenic mechanism of Vibrio vulnificus infection

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Heng SP, Letchumanan V, Deng CY et al. Vibrio vulnificus: an environmental and clinical burden. Front. Microbiol. 8, 997 (2017).
  MedlineGoogle Scholar
• 2. Coerdt KM, Khachemoune A. Vibrio vulnificus: review of mild to life-threatening skin infections. Cutis 107(2), e12–e17 (2021).
  MedlineGoogle Scholar
• 3. Wong KC, Brown AM, Luscombe GM et al. Antibiotic use for Vibrio infections: important insights from surveillance data. BMC Infect. Dis. 15, 226 (2015).
  MedlineGoogle Scholar
• 4. Jones MK, Oliver JD. Vibrio vulnificus: disease and pathogenesis. Infect. Immun. 77(5), 1723–1733 (2009). •• The biological types and possible pathogenesis of Vibrio vulnificus are summarized in detail.
  Medline CASGoogle Scholar
• 5. Chang CY, Wu KH, Wu PH et al. In-hospital mortality associated with necrotizing soft tissue infection due to Vibrio vulnificus: a matched-pair cohort study. World J. Emerg. Surg. 17(1), 28 (2022).
  MedlineGoogle Scholar
• 6. Hong G, Wu B, Lu C et al. Emergency treatment of 16 patients with necrotizing fasciitis caused by Vibrio vulnificus infection complicated with septic shock. Chin. Med. J. (Engl.) 127(10), 1984–1986 (2014).
  MedlineGoogle Scholar
• 7. Chao WN, Tsai CF, Chang HR et al. Impact of timing of surgery on outcome of Vibrio vulnificus-related necrotizing fasciitis. Am. J. Surg. 206(1), 32–39 (2013).
  MedlineGoogle Scholar
• 8. Zhao H, Xu L, Dong H et al. Correlations between clinical features and mortality in patients with Vibrio vulnificus infection. PLOS ONE 10(8), e0136019 (2015).
  MedlineGoogle Scholar
• 9. Stamm LV. Role of TLR4 in the host response to Vibrio vulnificus, an emerging pathogen. FEMS Immunol. Med. Microbiol. 58(3), 336–343 (2010).
  Medline CASGoogle Scholar
• 10. Anderson M, Knudson M, Frieberg E et al. Fatal Vibrio vulnificus sepsis in vertically acquired hepatitis C. J. Pediatr. Gastroenterol. Nutr. 56(5), e32–e33 (2013).
  MedlineGoogle Scholar
• 11. Bisharat N, Bronstein M, Korner M et al. Transcriptome profiling analysis of Vibrio vulnificus during human infection. Microbiology (Reading) 159(Pt 9), 1878–1887 (2013).
  Medline CASGoogle Scholar
• 12. Leng F, Lin S, Wu W et al. Epidemiology, pathogenetic mechanism, clinical characteristics, and treatment of Vibrio vulnificus infection: a case report and literature review. Eur. J. Clin. Microbiol. Infect. Dis. 38(11), 1999–2004 (2019).
  MedlineGoogle Scholar
• 13. Duong-Nu TM, Jeong K, Hong SH et al. A stealth adhesion factor contributes to Vibrio vulnificus pathogenicity: flp pili play roles in host invasion, survival in the blood stream and resistance to complement activation. PLoS Pathog. 15(8), e1007767 (2019).
  Medline CASGoogle Scholar
• 14. Murciano C, Lee CT, Fernandez-Bravo A et al. MARTX toxin in the zoonotic serovar of Vibrio vulnificus triggers an early cytokine storm in mice. Front. Cell Infect. Microbiol. 7, 332 (2017).
  MedlineGoogle Scholar
• 15. Li G, Wang MY. The role of Vibrio vulnificus virulence factors and regulators in its infection-induced sepsis. Folia. Microbiol. (Praha) 65(2), 265–274 (2020). •• Summarizes the role of V. vulnificus virulence factors in sepsis.
  Medline CASGoogle Scholar
• 16. Kashimoto T, Ueno S, Hayashi H et al. Depletion of lymphocytes, but not neutrophils, via apoptosis in a murine model of Vibrio vulnificus infection. J. Med. Microbiol. 54(Pt 1), 15–22 (2005).
  MedlineGoogle Scholar
• 17. Lo HR, Lin JH, Chen YH et al. RTX toxin enhances the survival of Vibrio vulnificus during infection by protecting the organism from phagocytosis. J. Infect. Dis. 203(12), 1866–1874 (2011).
  Medline CASGoogle Scholar
• 18. Chen CL, Chien SC, Leu TH et al. Vibrio vulnificus MARTX cytotoxin causes inactivation of phagocytosis-related signaling molecules in macrophages. J. Biomed. Sci. 24(1), 58 (2017).
  MedlineGoogle Scholar
• 19. Tsuchiya T, Mitsuo E, Hayashi N et al. Vibrio vulnificus damages macrophages during the early phase of infection. Infect. Immun. 75(9), 4592–4596 (2007).
  Medline CASGoogle Scholar
• 20. Lopez-Perez M, Jayakumar JM, Haro-Moreno JM et al. Evolutionary model of cluster divergence of the emergent marine pathogen Vibrio vulnificus: from genotype to ecotype. mBio 10(1), e02852-18 (2019).
  MedlineGoogle Scholar
• 21. Lee TH, Cha SS, Lee CS et al. Monoclonal antibodies against Vibrio vulnificus RtxA1 elicit protective immunity through distinct mechanisms. Infect. Immun. 82(11), 4813–4823 (2014).
  MedlineGoogle Scholar
• 22. Lee SJ, Jung YH, Oh SY et al. Vibrio vulnificus VvpE inhibits mucin 2 expression by hypermethylation via lipid raft-mediated ROS signaling in intestinal epithelial cells. Cell Death Dis. 6, e1787 (2015).
  Medline CASGoogle Scholar
• 23. Kim CM, Park RY, Chun HJ et al. Vibrio vulnificus metalloprotease VvpE is essentially required for swarming. FEMS Microbiol. Lett. 269(1), 170–179 (2007).
  Medline CASGoogle Scholar
• 24. Paranjpye RN, Strom MS. A Vibrio vulnificus type IV pilin contributes to biofilm formation, adherence to epithelial cells, and virulence. Infect. Immun. 73(3), 1411–1422 (2005).
  Medline CASGoogle Scholar
• 25. Wright AC, Simpson LM, Oliver JD. Role of iron in the pathogenesis of Vibrio vulnificus infections. Infect. Immun. 34(2), 503–507 (1981).
  Medline CASGoogle Scholar
• 26. Thiaville PC, Bourdage KL, Wright AC et al. Genotype is correlated with but does not predict virulence of Vibrio vulnificus biotype 1 in subcutaneously inoculated, iron dextran-treated mice. Infect. Immun. 79(3), 1194–1207 (2011).
  Medline CASGoogle Scholar
• 27. Garrett SB, Garrison-Schilling KL, Cooke JT et al. Capsular polysaccharide production and serum survival of Vibrio vulnificus are dependent on antitermination control by RfaH. FEBS Lett. 590(24), 4564–4572 (2016).
  Medline CASGoogle Scholar
• 28. Kim HY, Ayrapetyan M, Oliver JD. Survival of Vibrio vulnificus genotypes in male and female serum, and production of siderophores in human serum and seawater. Foodborne Pathog. Dis. 11(2), 119–125 (2014).
  Medline CASGoogle Scholar
• 29. Yun NR, Kim DM. Vibrio vulnificus infection: a persistent threat to public health. Korean J. Intern. Med. 33(6), 1070–1078 (2018).
  Medline CASGoogle Scholar
• 30. Hor LI, Chang YK, Chang CC et al. Mechanism of high susceptibility of iron-overloaded mouse to Vibrio vulnificus infection. Microbiol. Immunol. 44(11), 871–878 (2000).
  Medline CASGoogle Scholar
• 31. Simpson LM, Oliver JD. Siderophore production by Vibrio vulnificus. Infect. Immun. 41(2), 644–649 (1983).
  Medline CASGoogle Scholar
• 32. Barnes AD, Pfeifer HJ, Zbylicki BR et al. Two novel proteins, TtpB2 and TtpD2, are essential for iron transport in the TonB2 system of Vibrio vulnificus. MicrobiologyOpen 9(1), e00947 (2020).
  MedlineGoogle Scholar
• 33. Kustusch RJ, Kuehl CJ, Crosa JH. The ttpC gene is contained in two of three TonB systems in the human pathogen Vibrio vulnificus, but only one is active in iron transport and virulence. J. Bacteriol. 194(12), 3250–3259 (2012).
  Medline CASGoogle Scholar
• 34. Duong-Nu TM, Jeong K, Hong SH et al. All three TonB systems are required for Vibrio vulnificus CMCP6 tissue invasiveness by controlling flagellum expression. Infect. Immun. 84(1), 254–265 (2016).
  Medline CASGoogle Scholar
• 35. Datta S, Kenton RJ. Characterization of temperature-dependent hemin uptake receptors HupA and HvtA in Vibrio vulnificus. MicrobiologyOpen 8(10), e905 (2019).
  Medline CASGoogle Scholar
• 36. Kim CM, Park RY, Choi MH et al. Ferrophilic characteristics of Vibrio vulnificus and potential usefulness of iron chelation therapy. J. Infect. Dis. 195(1), 90–98 (2007).
  Medline CASGoogle Scholar
• 37. Kim YR, Lee SE, Kook H et al. Vibrio vulnificus RTX toxin kills host cells only after contact of the bacteria with host cells. Cell Microbiol. 10(4), 848–862 (2008).
  Medline CASGoogle Scholar
• 38. Lee JH, Rho JB, Park KJ et al. Role of flagellum and motility in pathogenesis of Vibrio vulnificus. Infect. Immun. 72(8), 4905–4910 (2004).
  Medline CASGoogle Scholar
• 39. Goo SY, Han YS, Kim WH et al. Vibrio vulnificus IlpA-induced cytokine production is mediated by Toll-like receptor 2. J. Biol. Chem. 282(38), 27647–27658 (2007).
  Medline CASGoogle Scholar
• 40. Goo SY, Lee HJ, Kim WH et al. Identification of OmpU of Vibrio vulnificus as a fibronectin-binding protein and its role in bacterial pathogenesis. Infect. Immun. 74(10), 5586–5594 (2006).
  Medline CASGoogle Scholar
• 41. Lee SJ, Jung YH, Oh SY et al. Vibrio vulnificus VvhA induces NF-κB-dependent mitochondrial cell death via lipid raft-mediated ROS production in intestinal epithelial cells. Cell Death Dis. 6, 1655 (2015).
  Medline CASGoogle Scholar
• 42. Song EJ, Lee SJ, Lim HS et al. Vibrio vulnificus VvhA induces autophagy-related cell death through the lipid raft-dependent c-Src/NOX signaling pathway. Sci. Rep. 6, 27080 (2016).
  Medline CASGoogle Scholar
• 43. Yuan Y, Feng Z, Wang J. Vibrio vulnificus hemolysin: biological activity, regulation of vvhA expression, and role in pathogenesis. Front. Immunol. 11, 599439 (2020). • This article summarizes the latest progress in understanding the regulation of VVHA gene expression, the biological activity of V. vulnificus hemolysin and its role in pathogenesis.
  Medline CASGoogle Scholar
• 44. Chung KJ, Cho EJ, Kim MK et al. RtxA1-induced expression of the small GTPase Rac2 plays a key role in the pathogenicity of Vibrio vulnificus. J. Infect. Dis. 201(1), 97–105 (2010).
  Medline CASGoogle Scholar
• 45. Lee BC, Choi SH, Kim TS. Vibrio vulnificus RTX toxin plays an important role in the apoptotic death of human intestinal epithelial cells exposed to Vibrio vulnificus. Microbes Infect. 10(14-15), 1504–1513 (2008).
  Medline CASGoogle Scholar
• 46. Kim YR, Lee SE, Kang IC et al. A bacterial RTX toxin causes programmed necrotic cell death through calcium-mediated mitochondrial dysfunction. J. Infect. Dis. 207(9), 1406–1415 (2013).
  Medline CASGoogle Scholar
• 47. Guo RH, Lim JY, Tra My DN et al. Vibrio vulnificus RtxA1 toxin expression upon contact with host cells is RpoS-dependent. Front. Cell. Infect. Microbiol. 8, 70 (2018).
  Medline CASGoogle Scholar
• 48. Gong Y, Guo RH, Rhee JH et al. TolCV1 has multifaceted roles during Vibrio vulnificus infection. Front. Cell. Infect. Microbiol. 11, 673222 (2021). • TolCV1 plays a key role in the RtxA1 secretion, drug resistance and lethality of V. vulnificus and may be an attractive target for designing new drugs to treat V. vulnificus infection.
  Medline CASGoogle Scholar
• 49. Guo RH, Gong Y, Kim SY et al. DIDS inhibits Vibrio vulnificus cytotoxicity by interfering with TolC-mediated RtxA1 toxin secretion. Eur. J. Pharmacol. 884, 173407 (2020). • Disodium 4,4′-diisothiocyanate stilbene-2,2′-disulfonate hydrate is a promising treatment model that inhibits the cytotoxicity of V. vulnificus by interfering with TolC-mediated RtxA1 toxin secretion.
  Medline CASGoogle Scholar
• 50. Fan JJ, Shao CP, Ho YC et al. Isolation and characterization of a Vibrio vulnificus mutant deficient in both extracellular metalloprotease and cytolysin. Infect. Immun. 69(9), 5943–5948 (2001).
  Medline CASGoogle Scholar
• 51. Kwak JS, Jeong HG, Satchell KJ. Vibrio vulnificus rtxA1 gene recombination generates toxin variants with altered potency during intestinal infection. Proc. Natl Acad. Sci. USA 108(4), 1645–1650 (2011).
  Medline CASGoogle Scholar
• 52. Jeong HG, Satchell KJ. Additive function of Vibrio vulnificus MARTX(Vv) and VvhA cytolysins promotes rapid growth and epithelial tissue necrosis during intestinal infection. PLoS Pathog. 8(3), e1002581 (2012).
  Medline CASGoogle Scholar
• 53. Cho C, Choi S, Kim MH et al. Vibrio vulnificus PlpA facilitates necrotic host cell death induced by the pore forming MARTX toxin. J. Microbiol. 60(2), 224–233 (2022).
  Medline CASGoogle Scholar
• 54. Elgaml A, Higaki K, Miyoshi S. Effects of temperature, growth phase and luxO-disruption on regulation systems of toxin production in Vibrio vulnificus strain L-180, a human clinical isolate. World J. Microbiol. Biotechnol. 30(2), 681–691 (2014).
  Medline CASGoogle Scholar
• 55. Kim SY, Lee SE, Kim YR et al. Regulation of Vibrio vulnificus virulence by the LuxS quorum-sensing system. Mol. Microbiol. 48(6), 1647–1664 (2003).
  Medline CASGoogle Scholar
• 56. Lee JH, Rhee JE, Park U et al. Identification and functional analysis of Vibrio vulnificus SmcR, a novel global regulator. J. Microbiol. Biotechnol. 17(2), 325–334 (2007).
  Medline CASGoogle Scholar
• 57. Jeong HS, Lee MH, Lee KH et al. SmcR and cyclic AMP receptor protein coactivate Vibrio vulnificus vvpE encoding elastase through the RpoS-dependent promoter in a synergistic manner. J. Biol. Chem. 278(46), 45072–45081 (2003).
  Medline CASGoogle Scholar
• 58. Shao CP, Lo HR, Lin JH et al. Regulation of cytotoxicity by quorum-sensing signaling in Vibrio vulnificus is mediated by SmcR, a repressor of hlyU. J. Bacteriol. 193(10), 2557–2565 (2011).
  Medline CASGoogle Scholar
• 59. Wen Y, Kim IH, Son JS et al. Iron and quorum sensing coordinately regulate the expression of vulnibactin biosynthesis in Vibrio vulnificus. J. Biol. Chem. 287(32), 26727–26739 (2012).
  Medline CASGoogle Scholar
• 60. Kim IH, Kim SY, Park NY et al. Cyclo-(l-Phe-l-Pro), a quorum-sensing signal of Vibrio vulnificus, induces expression of hydroperoxidase through a ToxR-LeuO-HU-RpoS signaling pathway to confer resistance against oxidative stress. Infect. Immun. 86(9), e00932-17 (2018).
  MedlineGoogle Scholar
• 61. Pei J, Wang H, Wu L et al. Biochemical characterization of a catalase from Vibrio vulnificus, a pathogen that causes gastroenteritis. Acta Biochim. Pol. 64(3), 543–549 (2017).
  Medline CASGoogle Scholar
• 62. Kim SP, Kim CM, Shin SH. Cyclic AMP and cyclic AMP-receptor protein modulate the autoinducer-2-mediated quorum sensing system in Vibrio vulnificus. Curr. Microbiol. 65(6), 701–710 (2012).
  Medline CASGoogle Scholar
• 63. Green J, Stapleton MR, Smith LJ et al. Cyclic-AMP and bacterial cyclic-AMP receptor proteins revisited: adaptation for different ecological niches. Curr. Opin. Microbiol. 18, 1–7 (2014).
  Medline CASGoogle Scholar
• 64. Fang FC, Frawley ER, Tapscott T et al. Bacterial stress responses during host infection. Cell Host Microbe 20(2), 133–143 (2016).
  Medline CASGoogle Scholar
• 65. Jang KK, Lee ZW, Kim B et al. Identification and characterization of Vibrio vulnificus plpA encoding a phospholipase A2 essential for pathogenesis. J. Biol. Chem. 292(41), 17129–17143 (2017).
  Medline CASGoogle Scholar
• 66. Jeong HS, Kim SM, Lim MS et al. Direct interaction between quorum-sensing regulator SmcR and RNA polymerase is mediated by integration host factor to activate vvpE encoding elastase in Vibrio vulnificus. J. Biol. Chem. 285(13), 9357–9366 (2010).
  Medline CASGoogle Scholar
• 67. Jeong HG, Choi SH. Evidence that AphB, essential for the virulence of Vibrio vulnificus, is a global regulator. J. Bacteriol. 190(10), 3768–3773 (2008). • It was demonstrated that AphB is a global regulatory factor that contributes to the pathogenesis of V. vulnificus.
  Medline CASGoogle Scholar
• 68. Kim WB, Lee BC, Choi SH. Vibrio vulnificus AphB is involved in interleukin-8 production via an NF-κB-dependent pathway in human intestinal epithelial cells. Biochem. Biophys. Res. Commun. 417(4), 1265–1270 (2012).
  Medline CASGoogle Scholar
• 69. Liu M, Crosa JH. The regulator HlyU, the repeat-in-toxin gene rtxA1, and their roles in the pathogenesis of Vibrio vulnificus infections. MicrobiologyOpen 1(4), 502–513 (2012).
  Medline CASGoogle Scholar
• 70. Liu M, Naka H, Crosa JH. HlyU acts as an H-NS antirepressor in the regulation of the RTX toxin gene essential for the virulence of the human pathogen Vibrio vulnificus CMCP6. Mol. Microbiol. 72(2), 491–505 (2009).
  Medline CASGoogle Scholar
• 71. Gauthier JD, Jones MK, Thiaville P et al. Role of GacA in virulence of Vibrio vulnificus. Microbiology (Reading) 156(Pt 12), 3722–3733 (2010).
  Medline CASGoogle Scholar
• 72. Brown RN, Gulig PA. Regulation of fatty acid metabolism by FadR is essential for Vibrio vulnificus to cause infection of mice. J. Bacteriol. 190(23), 7633–7644 (2008).
  Medline CASGoogle Scholar
• 73. Ho YC, Hung FR, Weng CH et al. Lrp, a global regulator, regulates the virulence of Vibrio vulnificus. J. Biomed. Sci. 24(1), 54 (2017).
  MedlineGoogle Scholar
• 74. Sun KN, Huang F, Wang MY et al. IL-21 enhances the immune protection induced by the Vibrio vulnificus hemolysin A protein. Inflammation 45(4), 1496–1506 (2022).
  Medline CASGoogle Scholar
• 75. Wang MY, Liu XF, Xia J et al. Vibrio vulnificus VvhA induces Th1 and Tfh cells to proliferate against Vibrio vulnificus in a mouse model of infection. Future Microbiol. 12, 953–965 (2017).
  CASGoogle Scholar
• 76. Shin SH, Shin DH, Ryu PY et al. Proinflammatory cytokine profile in Vibrio vulnificus septicemic patients’ sera. FEMS Immunol. Med. Microbiol. 33(2), 133–138 (2002).
  Medline CASGoogle Scholar
• 77. Lee NY, Lee HY, Lee KH et al. Vibrio vulnificus IlpA induces MAPK-mediated cytokine production via TLR1/2 activation in THP-1 cells, a human monocytic cell line. Mol. Immunol. 49(1–2), 143–154 (2011).
  Medline CASGoogle Scholar
• 78. Lee BC, Kim MS, Choi SH et al. Involvement of capsular polysaccharide via a TLR2/NF-κB pathway in Vibrio vulnificus-induced IL-8 secretion of human intestinal epithelial cells. Int. J. Mol. Med. 25(4), 581–591 (2010).
  Medline CASGoogle Scholar
• 79. Lee BC, Kim MS, Cho D et al. Co-culture supernatants from Vibrio vulnificus-infected INT-407 cells induce IL-8 production in intestinal epithelial cells: crucial role of V. vulnificus rtxE. Int. J. Mol. Med. 26(5), 651–659 (2010).
  Medline CASGoogle Scholar
• 80. Toma C, Higa N, Koizumi Y et al. Pathogenic Vibrio activate NLRP3 inflammasome via cytotoxins and TLR/nucleotide-binding oligomerization domain-mediated NF-κB signaling. J. Immunol. 184(9), 5287–5297 (2010).
  Medline CASGoogle Scholar
• 81. Qin K, Fu K, Liu J et al. Vibrio vulnificus cytolysin induces inflammatory responses in RAW264.7 macrophages through calcium signaling and causes inflammation in vivo. Microb. Pathog. 137, 103789 (2019).
  Medline CASGoogle Scholar